Free shipping on all orders over $ 500

Nutlin-3

Cat. No. M2185
Nutlin-3 Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
2mg USD 60  USD60 In stock
5mg USD 90  USD90 In stock
10mg USD 126  USD126 In stock
50mg USD 466  USD466 In stock
100mg USD 776  USD776 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Nutlin-3 is a small molecule inhibitor of the MDM2/p53 interaction, which leads to the non-genotoxic p53 stabilization, activation of cell cycle arrest and apoptosis pathways. Nutlin-3 inhibits the MDM2-p53 interaction with IC50 of 0.09 μM and synergistically activates p53 to suppress tumor growth. Nutlin-3 induces apoptosis in cancer cells. Nutlin-3 treatment induces the expression of MDM2 and p21, and displays potent antiproliferative activity with IC50 of ~1.5 μM in cells with wild-type p53 such as HCT116, RKO and SJSA-1. Nutlin-3 is currently in phase I clinical trial for the treatment of retinoblastoma.

Product Citations
Customer Product Validations & Biological Datas
Source Johann Wolfgang Goethe-Universität (2017). Figure 42. Nutlin (AbMole Bioscience; Houston, TX, USA)
Method Western Blot
Cell Lines UKF-NB-3 und UKF-NB-6 Zellen
Concentrations 1 μM
Incubation Time 24 h
Results Auch hier ist durch die kombinierte Behandlung mit 10 nM YM155 und 1 μM Nutlin-3 eine 15-fache Erhöhung des p21 Proteinlevels in UKF-NB-3 zu beobachten. Ebenfalls erfolgt ein Anstieg der γH2A.X Expression
Source Johann Wolfgang Goethe-Universität (2017). Figure 41. Nutlin (AbMole Bioscience; Houston, TX, USA)
Method Western Blot
Cell Lines UKF-NB-3 und UKF-NB-6 Zellen
Concentrations 1 μM
Incubation Time 24 h
Results Anhand der Quantifizierung ist in Abb. 41 A zu erkennen, dass die Nutlin-3 Behandlung (1 μM) einen signifikanten Anstieg von p53 in UKF-NB-3 bewirkt (3-fach).
Source Johann Wolfgang Goethe-Universität (2017). Figure 40. Nutlin (AbMole Bioscience; Houston, TX, USA)
Method Western Blot
Cell Lines UKF-NB-3 und UKF-NB-6 Zellen
Concentrations 1 μM
Incubation Time 24 h
Results Um diesen Effekt genauer zu untersuchen, wurde im Western-Blot geprüft, inwiefern die kombinierte YM155 und Nutlin-3 Behandlung einen Einfluss auf die Expression entsprechender Proteine in UKF-NB-3 und UKF-NB-6 Zellen ausübt
Source Johann Wolfgang Goethe-Universität (2017). Figure 39. Nutlin (AbMole Bioscience; Houston, TX, USA)
Method Western Blot
Cell Lines UKF-NB-3 und UKF-NB-6 Zellen
Concentrations 1 μM
Incubation Time 24 h
Results Eine kombinierte Behandlung der UKF-NB-3 und UKF-NB-6 Zellen mit 0,625 nM YM155 und 1 μM Nutlin-3 zeigt einen signifikant verstärkenden Effekt in beiden Zelllinien
Source Vitrual Biology (2015). Figure 3. Nutlin-3
Method Test for vitality with resazurin
Cell Lines NSCLC cells
Concentrations 30 μM
Incubation Time 24 h
Results On Figure 3 we selected several pathways that demonstrated an interesting dynamic in the change of significance (measured as -Log2(p-value)) of the moderately resistant cell lines in comparison with sensitive cell lines in different conditions with increased dosage of treatment by Nutlin-3.
Source Vitrual Biology (2015). Figure 1. Nutlin-3
Method Test of sensitivity of NSCLC cells to Nutlin-3
Cell Lines NSCLC cells
Concentrations 30 μM
Incubation Time 24 h
Results For further analysis we selected three cell lines: one, which was the most sensitive to Nutlin-3 – the H1944 cell line, and two, which were still reacting to Nutlin-3, but only under relatively high concentrations – H292 and A427
Protocol (for reference only)
Cell Experiment
Cell lines wild-type p53 (HCT116, RKO, and SJSA-1) and mutant p53 (MDA-MB-435 and SW480) cell lines
Preparation method Effect of the enantiomers of Nutlin-3 on the growth and viability of cancer cells with wild-type p53 (HCT116, RKO, and SJSA-1) and mutant p53 (MDA-MB-435 and SW480). Cells were grown, treated, and analyzedAntiproliferative and cytotoxic activity of Nutlin-1. Exponentially growing cancer cells with wild-type p53 (HCT116, RKO, and SJSA-1) or mutant p53 (MDA-MB-435 and SW480) were incubated with a range of concentrations for 5 days and the cell mass and viability were measured by the MTT assay.
Concentrations 0~30µM
Incubation time 5 days
Animal Experiment
Animal models Nude mice bearing subcutaneous human cancer xenografts
Formulation 2% Klucel, 0.5% Tween 80
Dosages 200 mg/kg twice daily for 3 weeks
Administration oral gavage
Chemical Information
Molecular Weight 581.49
Formula C30H30Cl2N4O4
CAS Number 548472-68-0
Solubility (25°C) DMSO ≥ 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Zhang Y, et al. Cancer Biol Ther. Inauhzin and Nutlin3 synergistically activate p53 and suppress tumor growth.

[2] Secchiero P, et al. Curr Pharm Des. Recent advances in the therapeutic perspectives of Nutlin-3.

[3] LaRusch GA, et al. Cancer Res. Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1alpha and Hdm2.

Related Mdm2 Products
MMRi64

MMRi64 disrupts Mdm2-MdmX interactions.

MeOIstPyrd

MeOIstPyrd is an anti-skin cancer agent.

MDM2/XIAP-IN-3

MDM2/XIAP-IN-3 is a dual MDM2/XIAP inhibitor.

UNP-6457

UNP-6457 is a potent active MDM2-p53 interaction inhibitor with an IC50 values of 8.9 nM.

YL93

YL93 is a dual inhibitors of MDM2/4 with Ki values of 0.64 μM and 1.1 nM for MDM4 and MDM2, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: Nutlin-3 supplier, Mdm2, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.